[Remote] Senior Director, Clinical Operations at Abata Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Over 10 years of experience in clinical operations, preferably in a biotechnology or pharmaceutical company
Proven track record of managing global clinical trials, including overseeing project timelines, budgets, and resources
Strong leadership and management skills, with experience in directing cross-functional teams
Excellent communication and interpersonal skills, with the ability to effectively manage relationships with external partners and internal stakeholders
Experience with regulatory compliance, including ICH/GCP and regulatory submissions
Strong analytical and problem-solving skills, with the ability to identify best practices and optimize operational efficiency
Bachelor's degree in a life science, business, or a related field
Professional certifications, such as CRO or CMO, are a plus
Experience with clinical trial management systems (CTMS) and electronic data capture (EDC) systems
Strong understanding of pharmaceutical regulations, including FDA guidelines and GMP requirements

Responsibilities

Oversee and direct relevant clinical operations resources
Contribute to strategy, tactics, and driving execution of multiple global clinical programs
Influence, oversee, and lead planning, budgeting, and study management processes in global clinical studies
Leads direct reports to successfully manage external service providers and internal cross-functional colleagues
Develop and implement department-level SOPs for clinical trials and related activities
Interface with departments within and outside of Clinical, including Finance, Regulatory Affairs, Legal Affairs, and Business Development
Represent the company at Investigator Meetings
Participate in clinical data review and submission activities
Develop training plans and conduct performance reviews for direct reports
Manage relationships with pharmaceutical partners and suppliers in clinical programs

Skills

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free